On the same line, Cetuximab, an EGFR inhibitor, when conjugated with fluorescent dye (IRDye 800), was used to identify glioblastoma tissue, with an optimal signal to background ratio and adequate tumor visualization according to preliminary data (Miller et al., 2018). The gene discussed is EGFR; the disease is glioblastoma.